Form 4: Rivian CEO Robert Scaringe Executes Stock Transactions Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Rivian's CEO, Robert Scaringe, executed a series of stock transactions, including the exercise of stock options and the sale of shares, under a pre-arranged 10b5-1 trading plan.

Summary

  • Rivian CEO Robert Scaringe exercised stock options to acquire 71,429 shares of Class A Common Stock at a price of $2.6282 per share on December 23, 2024.
  • On the same day, Scaringe sold 71,429 shares of Class A Common Stock at a weighted average price of $13.878 per share, with individual sales ranging from $13.725 to $14.075.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 8, 2024.
  • Following these transactions, Scaringe directly owns 863,361 shares of Class A Common Stock and indirectly owns 4,595 shares through an LLC and 2,632,766 shares through a trust.
  • Scaringe also holds 7,820,976 stock options.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself. The use of a 10b5-1 plan indicates a planned and expected transaction.

Industry Context

This is a routine filing related to insider trading activity, which is common for executives of publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

  • The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, including those in the automotive and technology sectors, such as Tesla and Lucid.
  • The reported transactions are typical for executives who receive stock options as part of their compensation packages.
  • The price range of the stock sale is within the normal fluctuations of the market.

Stakeholder Impact

  • The transactions may have a minor impact on the stock price, but the use of a 10b5-1 plan suggests that the transactions were planned and not based on any new material information.
  • The transactions do not have a direct impact on employees, customers, or suppliers.

Key Dates

DateDescription
2023-02-14Stock options fully vested.
2024-03-0810b5-1 trading plan adopted.
2024-05-07Reference to the filing of the Issuer's Quarterly Report on Form 10-Q for the three months ended March 31, 2024.
2024-12-23Stock options exercised and shares sold.
2024-12-26Date of filing.

Keywords

Rivian, Robert Scaringe, stock options, stock sale, 10b5-1 plan, insider trading, Class A Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.